CHIRP brings scientists and clinicians from various disciplines throughout Washington University together to conduct clinical research using psychedelics as medical treatment.
The research team investigates the how, why and for whom psychedelic treatments may be effective, and how those treatments may work in real-world settings.
Our research team draws upon extensive experience conducting industry sponsored clinical trials and in the designing and implementation of our own studies.
We are the first clinical research group in the state of Missouri and one of less than 30 academic centers in the United States conducting clinical research safely and legally with Schedule 1 medications like psilocybin.
We would love to hear about your research idea or project. Our team guides researchers in setting up their own clinical trial.
- Protocol development
- Regulatory support
- Study implementation
- Psychedelic Assisted Therapy resources
Visit our guide to find tools to assist in conducting your research from start up to close out. New tools are continually being added based.